๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Safety of Liver Resections in Obese and Overweight Patients

โœ Scribed by Silvio Balzan; Ganesh Nagarajan; Olivier Farges; Claudio Zettler Galleano; Safi Dokmak; Catherine Paugam; Jacques Belghiti

Publisher
Springer
Year
2010
Tongue
English
Weight
203 KB
Volume
34
Category
Article
ISSN
0364-2313

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Safety of hepatic resection in overweigh
Safety of hepatic resection in overweight and obese patients with cirrhosis
โœ A. Cucchetti; M. Cescon; G. Ercolani; P. Di Gioia; E. Peri; A. D. Pinna ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 149 KB ๐Ÿ‘ 2 views

## Abstract ## Background The simultaneous incremental increase in incidence of both obesity and hepatocellular carcinoma (HCC) will soon lead to more overweight and obese patients with cirrhosis needing surgery. At present, little is known about postoperative mortality and morbidity in such patie

Role of ethnicity in overweight and obes
Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis
โœ Romina Lomonaco; Carolina Ortiz-Lopez; Beverly Orsak; Joan Finch; Amy Webb; Fern ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 265 KB ๐Ÿ‘ 1 views

The role of ethnicity in determining disease severity in nonalcoholic steatohepatitis (NASH) remains unclear. We recruited 152 patients with biopsy-proven NASH, 63% of whom were Hispanic and 37% of whom were Caucasian. Both groups were well matched for age, sex, and total body fat. We measured: (1)

Feasibility and diagnostic performance o
Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients
โœ Robert P. Myers; Gilles Pomier-Layrargues; Richard Kirsch; Aaron Pollett; Andres ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 400 KB

Failure of liver stiffness measurement (LSM) by transient elastography (TE, FibroScan) and unreliable results occur in %5% and 15% of patients, respectively, mainly due to obesity. In this multicenter study, we evaluated the feasibility and performance of the novel FibroScan XL probe in 276 patients